Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $138.21 million as of April 18, 2024. Its market cap has increased by 833.88% in one year.

Market Cap

138.21M

Enterprise Value

140.29M

1-Year Change

833.88%

Ranking

n/a

Market Cap Chart

Since February 24, 2000, Elite Pharmaceuticals's market cap has increased from $114.50M to $138.21M, an increase of 20.71%. That is a compound annual growth rate of 2.06%.

Market Cap History

Date	Market Cap	% Change
May 21, 2009	3.50M	-10.26%
May 20, 2009	3.90M	-
May 19, 2009	3.90M	-
May 18, 2009	3.90M	-7.14%
May 15, 2009	4.20M	7.69%
May 14, 2009	3.90M	-
May 13, 2009	3.90M	-7.14%
May 12, 2009	4.20M	-
May 11, 2009	4.20M	-
May 8, 2009	4.20M	-8.70%
May 7, 2009	4.60M	84.00%
May 6, 2009	2.50M	-
May 5, 2009	2.50M	19.05%
May 4, 2009	2.10M	-16.00%
May 1, 2009	2.50M	-
Apr 30, 2009	2.50M	-28.57%
Apr 29, 2009	3.50M	-
Apr 28, 2009	3.50M	-10.26%
Apr 27, 2009	3.90M	-7.14%
Apr 24, 2009	4.20M	-
Apr 23, 2009	4.20M	-
Apr 22, 2009	4.20M	20.00%
Apr 21, 2009	3.50M	-
Apr 20, 2009	3.50M	-16.67%
Apr 17, 2009	4.20M	-8.70%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	717.29B
Novo Nordisk	565.54B
UnitedHealth Group	411.83B
Johnson & Johnson	356.69B
Merck & Co.	320.40B
AbbVie	287.71B
AstraZeneca	213.53B
Thermo Fisher	212.65B

Market Cap Rankings